Upadacitinib Resolves Secukinumab-Induced Atopic Dermatitis: Case Report
A Frontiers case report documents upadacitinib clearing atopic dermatitis in a patient whose skin disease was triggered by secukinumab during refractory ankylosing spondylitis therapy, prompting a JA…
